JACLYN ROGERS: Open Payments
NPI 1972868651 · AUSTELL, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,000 in 21 payments from 10 companies in 2025. Trend: 2023 $51 · 2024 $0 · 2025 $1,000
Food & beverage: $916Education: $84
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $346 |
| ABBVIE INC. | 3 | $161 |
| FUJIFILM Healthcare Americas Corporation | 1 | $154 |
| Regeneron Healthcare Solutions, Inc. | 3 | $148 |
| Madrigal Pharmaceuticals | 2 | $79 |
| GENZYME CORPORATION | 1 | $30 |
| QOL Medical, LLC | 1 | $26 |
| Ipsen Biopharmaceuticals, Inc | 1 | $22 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
Products named: TREMFYA, UTASWAKO AFP-L3, DUPIXENT, REZDIFFRA, MAVYRET, Sucraid, IQIRVO, XIFAXAN.
Industry payments across GA — which companies pay providers there.
